Synergy Pharmaceuticals (SGYP) Trulance Weekly Rx Trends Continue to Track Ahead of Projections - BTIG
Tweet Send to a Friend
BTIG analyst Timothy Chiang reiterated a Buy rating and $11 price target on Synergy Pharmaceuticals (NASDAQ: SGYP) saying Trulance weekly ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
